Relationship between Neuron-specific Enolase Serum Levels with Lesion Volume and Clinical Outcome in Acute Stroke Patients
DOI:
https://doi.org/10.3889/oamjms.2022.8431Keywords:
Acute stroke, Hemorrhagic stroke, Ischemic stroke, Neuron-specific enolaseAbstract
BACKGROUND: Neuron-specific enolase (NSE) is released in the cerebrospinal fluid and bloodstream in response to brain damage. Serum NSE levels can be used as a marker of brain nerve cells either in ischemic or hemorrhagic stroke, associated with lesion volume and functional outcome.
AIM: The aim of the study was to evaluate the correlation between NSE serum level with lesion volume and functional outcome in acute stroke patients.
METHODS: A cross-sectional study was conducted on 29 patients with ischemic stroke and 29 hemorrhagic strokes admitted to Haji Adam General Hospital. All the subjects were assessed with the National Institute of Health Stroke Scale (NIHSS) score, modified Rankin scale (mRS), and assessment of lesion volume.
RESULTS: Subjects consist of 27 male (46.4%) and 31 female (53.4%), with mean age of 61.67 ± 12.26 years. The mean serum NSE levels in stroke patients were 19.79 ± 8.88 ng/ml and lesion volume was 25.09 ± 24.52 ml. There was a significant positive correlation of increase in serum NSE levels with infarct volume (r = 0.863 and p < 0.001) and hemorrhagic volume (r = 0.644 and p < 0.001) and clinical outcome assessed by NIHSS score (r = 0.761 and p < 0.001) and mRS score (r = 0.762 and p < 0.001) in ischemic stroke and NIHSS score (r = 0.525 and p = 0.003), and mRS score (r = 0.468 and p = 0.010) in hemorrhagic stroke.
CONCLUSION: High NSE serum levels in the acute phase were associated with lesion volume and poor outcomes in stroke patients.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Koton S, Schneider AL, Rosamond WD, Shahar E, Sang Y, Gottesman RF, et al. Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA. 2014;312(3):259-68. https://doi.org/10.1001/jama.2014.7692 PMid:25027141 DOI: https://doi.org/10.1001/jama.2014.7692
Ahmad O, Wardlaw J, Whiteley WN. Correlation of levels of neuronal and glial markers with radiological measures of infarct volume in ischaemic stroke: A systemic review. Cerebrovasc Dis. 2012;33(1):47-54. https://doi.org/10.1159/000332810 PMid:22133844 DOI: https://doi.org/10.1159/000332810
Lukas DL, Retnowati E, Islam S. Role of Serum Neuron Enolase (NSE) to differentiate ischemic stroke from hemorrhagic stroke and its correlation with brain damage volume. Folia Med Indones. 2007;43(4):230-4.
Maas MB, Furie KL. Molecular biomarkers in stroke diagnosis and prognosis. Biomark Med. 2009;3(4):363-83. https://doi.org/10.2217/bmm.09.30 PMid:20160867 DOI: https://doi.org/10.2217/bmm.09.30
Anand N, Stead LG. Neuron-specific enolase as a marker for acute ischemic stroke: A systemic review. Cerebrovasc Dis. 2005;20(4):213-9. https://doi.org/10.1159/000087701 PMid:16123539 DOI: https://doi.org/10.1159/000087701
Pandey A, Saxena K, Verma M, Bharosay A. The correlative study between neuron-specific enolase and blood sugar level in ischemic stroke patients. J Neurosci Rural. 2011;2(1):50-5. https://doi.org/10.4103/0976-3147.80099 PMid:21716874 DOI: https://doi.org/10.4103/0976-3147.80099
Wardiyani NS, Nurimaba N, Kurniani N. Correlation of Serum Neuron Spesific Enolase with Severity and functional Outcome in Acute Atherothrombotic infacrtion Stroke Patients. Majalah Kedokteran Bandung. 2010;42(2):62-8. DOI: https://doi.org/10.15395/mkb.v42n2.218
Singh HV, Pandey A, Shrivastava AK, Raizada A, Singh SK, Singh N. Prognostic value of neuron-specific enolase and IL-10 in ischemic stroke and its correlation with the degree of neurological deficit. Clin Chim Acta. 2013;419:136-8. https://doi.org/10.1016/j.cca.2013.02.014 PMid:23438682 DOI: https://doi.org/10.1016/j.cca.2013.02.014
Kim BJ, Kim Y, Ahn SH, Kim NY, Kang DW, Kim JS, et al. The second elevation of neuron-specific enolase peak after ischemic stroke is associated with hemorrhagic transformation. J Stroke Cerebrovasc Dis. 2014;23(9):2437-43. https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.05.020 PMid:25183561 DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.05.020
Ramachandra P, Sangita P, Sonali B, Rahul G, Dhananjay A. Study of neuron-specific enolase as potential biomarker for assessing the severity and outcome in patients with cerebrovascular accidents. Glob J Med Res. 2014;14(3):9-13.
Baidya OP, Tiwari S, Usman K. Role of neuron specific enolase in differentiating the side of brain lesion in acute ischemic stroke. Int J Biomed Res. 2015;6(8):570-3. https://doi.org/10.7439/ijbr.v6i8.2389 DOI: https://doi.org/10.7439/ijbr.v6i8.2389
Baidya OP, Tiwari S, Usman K. Serum neuronal-specific enolase as a biomarker in differentiating the side of brain lesion in acute hemorrhagic stroke: A hospital-based study. Int J Res Med Sci. 2016;4(5):1609-12. https://doi.org/10.18203/2320-6012.ijrms20161235 DOI: https://doi.org/10.18203/2320-6012.ijrms20161235
Isgro MA, Bottoni P, Scatena R. Neuron-spesific enolase as a biomarker: Biochemical and clinical aspects. Adv Exp Med Biol. 2015;867:125-43. https://doi.org/10.1007/978-94-017-7215-0_9 PMid:26530364 DOI: https://doi.org/10.1007/978-94-017-7215-0_9
Bharosay A, Bharosay VV, Varma M, Saxena K, Sodani A, Saxena R. Correlation of brain biomarker neuron specific enolase (NSE) with degree of disability and neurological worsening in cerebrovascular stroke. Ind J Clin Biochem. 2012;27(2):186-90. https://doi.org/10.1007/s12291-011-0172-9 PMid:23542317 DOI: https://doi.org/10.1007/s12291-011-0172-9
Sims JR, Gharai LR, Schaefer PW, Vangel M, Rosenthal ES, Lev MH, et al. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology. 2010;72(24):2104-10. https://doi.org/10.1212/WNL.0b013e3181aa5329 PMid:19528517 DOI: https://doi.org/10.1212/WNL.0b013e3181aa5329
Weimar C, Kurth T, Kraywinkel K, Wagner M, Busse O, Haberl RL, et al. Assesment of Functioning and disability after ischemic stroke. Stroke. 2002;33(8):2053-9. https://doi.org/10.1161/01.str.0000022808.21776.bf PMid:12154262 DOI: https://doi.org/10.1161/01.STR.0000022808.21776.BF
Abdillah R, Armenia A, Anggadireja K. The Impact of Citicoline Sociodemographic characteristics and Comorbidity on Glasgow Coma Scale (GCS) in Stroke Patients in RSUP dr. M. Djamil Padang. JSTF. 2017;19(1):89-95.
Putri MN, Mutiawati E, dan Mahdani W. Relationship Degree Stroke on The Cognitive Status Patients Ischemic Stroke Neurology polyclinic dr. Zainoel Abidin Banda Aceh. J Ilmiah Mahasiswa Med. 2017;2(1):61-7.
Zhang J, Wang Y, Wang G, Sun H, Sun T, Shi J, et al. Clinical factors in patients with ischemic versus hemorrhagic stroke in East China. World J Emerg Med. 2011;2(1):18-23. https://doi.org/10.5847/wjem.j.1920-8642.2011.01.003 PMid:25214977 DOI: https://doi.org/10.5847/wjem.j.1920-8642.2011.01.003
Ospanov O, Ospanova K, Kadyrova I. Neuron-specific enolase level in patients with metabolic syndrome and its value forecasting acute stroke. AMJ. 2018;11(3):186-94. https://doi.org/10.21767/AMJ.2018.3353 DOI: https://doi.org/10.21767/AMJ.2018.3353
Wang S, Zha X, Zhu X, Li W, Ma J, Wu Z, et al. Metabolic syndrome and its components with neuron-specific enolase: A cross-sectional study in a large health check-up population in China. BMJ. 2018;8(4):e020899. https://doi.org/10.1136/bmjopen-2017-020899 PMid:29643166 DOI: https://doi.org/10.1136/bmjopen-2017-020899
Zaheer S, Beg M, Rizvi I, Islam N, Ullah E, Akhtar N. Correlation between serum neuron-specific enolase and functional neurological outcome in patients of acute ischemic stroke. Ann Indian Acad Neurol. 2013;16(4):504-8. https://doi.org/10.4103/0972-2327.120442 PMid:24339568 DOI: https://doi.org/10.4103/0972-2327.120442
Najmi E, Bahbah EI, Negida A, Afifi A, Baratloo A. Diagnostic value of serum neuron-specific enolase level in patients with acute ischemic stroke: A systematic review and meta-analysis. Int Clin Neurosci J. 2019;6(2):36-41. DOI: https://doi.org/10.15171/icnj.2019.08
Haque A, Polcyn R, Matzelle D, Banik NL. New insights into the role of neuron-specific enolase in neuro-inflammation, neurodegeneration, and neuroprotection. Brain Sci. 2018;8(33):33. https://doi.org/10.3390/brainsci8020033 PMid:29463007 DOI: https://doi.org/10.3390/brainsci8020033
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Irina Kemala Nasution, Steviyani Bangun (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0